LCMV gp33 peptide KAVYNFATM (H-2 Db)

Single peptide synthesized as presented by the MHC class I allele
LCMV gp33 peptide KAVYNFATM (H-2 Db) is a single peptide for stimulation of T cells. The peptide from lymphocytic choreomeningitis virus (LCMV) glycoprotein 33 (gp33) is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.


Form: Lyophilized powder
Peptide Sequence: KAVYNFATM
Possible Application: T cell stimulation
Purity: > 85%
Sterility: Sterile
MHC I Compatibility: H-2 Db

Shipping information

Storage: -20 °C
Stability: 12 months after shipping
Shipping: Room temperature

Related Products

CD8 Fab-TACS® Agarose Column Starter Kit, mouse
Label-free isolation of cytotoxic T cells from murine splenocytes
MHC I-Strep H-2 Db; gp33 LCMV (KAVYNFATM)
MHC class I molecule fused to a Twin-Strep-tag® and refolded with a peptide